Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · IEX Real-Time Price · USD
6.88
-0.16 (-2.27%)
At close: Aug 12, 2022 4:00 PM
6.65
-0.23 (-3.34%)
After-hours: Aug 12, 2022 7:59 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Year 20202019
Revenue
0.120.1
Revenue Growth (YoY)
23.97%-
Cost of Revenue
0.130.05
Gross Profit
-0.010.05
Selling, General & Admin
0.510.61
Research & Development
0.120.09
Operating Expenses
0.640.7
Operating Income
-0.64-0.65
Interest Expense / Income
0.030.09
Other Expense / Income
-0.02-0.03
Pretax Income
-0.65-0.71
Net Income
-0.65-0.71
Net Income Common
-0.65-0.71
Shares Outstanding (Basic)
21
Shares Outstanding (Diluted)
21
Shares Change
130.43%-
EPS (Basic)
-0.41-1.14
EPS (Diluted)
-0.41-1.14
Free Cash Flow Per Share
-0.24-0.71
Gross Margin
-7.60%45.80%
Operating Margin
-520.50%-652.10%
Profit Margin
-525.80%-711.30%
Free Cash Flow Margin
-476.60%-745.50%
EBITDA
-0.62-0.62
EBITDA Margin
-502.60%-620.50%
EBIT
-0.62-0.62
EBIT Margin
-502.60%-620.50%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).